Covid19, Influenza, Pneumonia, Vaccine Refusal
Conditions
Keywords
African American, Latinx, Vaccine, Hispanic, Latino, COVID19 Vaccine
Brief summary
This proposed study seeks to community knowledge and understand the experience of underserved communities in the exploration of reducing health disparities and increasing vaccine uptake and acceptability COVID-19, influenza, and pneumonia for AA and Latinx populations. Unique in its design, it has the following characteristics: 1) multifaceted, 2) culturally tailored, 3) community-based, and 4) mixed methods in which the outcomes of interest will be measured before and after the intervention with 18-month interval. Furthermore, we seek to enhance our partnerships and collaborations with churches in South Los Angeles by supporting efforts to encourage COVID-19, influenza, and pneumonia vaccination uptake among underserved minorities in one of the most challenged and hard-to-reach population areas in the nation.
Detailed description
This study seeks to augment community knowledge and increase vaccine uptake among under-resourced African American and Latinx communities in South LA via leveraging trusted church leaders, educators and influencers to delivering COVID-19, influenza, and pneumonia education on vaccination. Unique in its design, this study has the following characteristics, beneficial to the acceptability and success of the proposal, it is: 1) multifaceted, 2) culturally tailored, and 3) community-based, in which the outcomes of interest will be compared longitudinally between arms 1-3, including measurement before and after the intervention with 9- and 18-month interval.
Interventions
BEHAVIORALFull VEPMP Intervention
Delivery of intrapersonal/interpersonal (i.e., motivational interviewing, vaccine educators, personal testimony, etc.), AND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.)
BEHAVIORALPartial VEPMP Intervention
Delivery of iAND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.)
BEHAVIORALDelayed VEPMP Intervention
Delayed implementation of delivery of intrapersonal/interpersonal AND organizational after 1 year of study start
Sponsors
Charles Drew University of Medicine and Science
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
The VEPMP will consist of recruited churches in 15 cohorts of 2 churches per cohort (total n = 30). Each cohort of church will include an AA and a Latinx church. The 15 church cohorts will be randomized to three arms based on a 1:1:1 ratio, using an online random number generator.
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Parishioner at a church receiving the VEPMP intervention * Identify as African American or Latinx, * at least 65 years and older * Have Not received a vaccine for COVID-19, influenza, or pneumonia within the previous 24 months * Agrees to study terms, which include follow-up interviews 9 and 18 months after study enrollment
Exclusion criteria
* Does not attend or identify as a Parishioner at a church receiving the VEPMP intervention * Does not identify as African American or Latinx * Under the age of 65 years * Received all vaccine doses for COVID-19, influenza, or pneumonia within the previous 24 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self Report | Intervention: 12 months; Follow-up Point: 9 & 18 months post-intervention | By comparison of pre-, post- intervention, and 9- and 18-months follow-up data, we anticipate the following compared to baseline: a 30% change in uptake for vaccination. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Participants Achieving Adherence to COVID-19, influenza, and pneumonia vaccination schedules Risk Using the NIH Toolbox Surveys on COVID-19 | Intervention: 12 months; Follow-up Point: 9 & 18 months post-intervention | By comparison of pre-, post- intervention, and 9 and 18-months follow-up data, we anticipate the following compared to baseline: a 30% change in adherence to COVID-19, influenza, and pneumonia vaccination schedules. |
| Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19, influenza, and pneumonia Using the NIH Toolbox Surveys on COVID-19, influenza, and pneumonia | Intervention: 12 months; Follow-up Point: 9 & 18 months post-intervention | By comparison of pre-, post- intervention, and 9 and 18-months follow-up data, we anticipate the following compared to baseline: a 40% change in vaccine hesitancy toward COVID-19, influenza, and pneumonia vaccination |
| Percentage of Participants Achieving Decreased Levels of COVID-19, influenza, and pneumonia Mistrust and Barriers Using the NIH Toolbox Surveys on COVID-19, influenza, and pneumonia | Intervention: 12 months; Follow-up Point: 9 & 18 months post-intervention | By comparison of pre-, post- intervention, and 9 and 18-months follow-up data, we anticipate the following compared to baseline: a 40% change in mistrust and perceived barriers toward COVID-19, influenza, and pneumonia vaccination |
Countries
United States
Outcome results
None listed